Logo

Geneart

In Brief This Week: Sequenom; Geneart, Life Technologies; Thermo Fisher Scientific; Spartan Bioscience; BioTime

In Brief This Week is a column containing news items that our readers may have missed during the week.

Geneart Posts 16 Percent Revenue Growth for Q3

The firm, which now majority-owned by Life Technologies, also posted a sharp gain in its earnings before interest and taxes.

Life Technologies Acquires Majority Stake in Geneart for $47M

Life Tech now owns 74 percent of the synthetic gene company.

UPDATE: Geneart Boards Recommend Acceptance of Life Tech Acquisition Bid

Life Technologies has made a tender offer to acquire the remaining shares of Geneart that it does not already own for around €25.5 million. The total purchase price was approximately €56 million.

UPDATE: Life Technologies Takes Majority Stake in GeneArt

The agreement gives Applied Biosystems Deutschland approximately 58 percent of GeneArt's shares.